• Explore /
  • Poster
  • / Cabozantinib real-world effectiveness in the first through fourth-line settings for the treatment of metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).

Cabozantinib real-world effectiveness in the first through fourth-line settings for the treatment of metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).

Abstract Poster

Authors

null

Chun Loo Gan

Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada

Chun Loo Gan , Shaan Dudani , Connor Wells , Frede Donskov , Sumanta K. Pal , Nazli Dizman , Nityam Rathi , Benoit Beuselinck , Flora Yan , Aly-Khan A. Lalani , Aaron Richard Hansen , Bernadett Szabados , Guillermo de Velasco , Ben Tran , Jae-Lyun Lee , Ulka N. Vaishampayan , Georg A. Bjarnason , Mathushan Subasri , Toni K. Choueiri , Daniel Yick Chin Heng

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer

Track

Renal Cell Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr 639)

Abstract #

639

Poster Bd #

E3

Abstract Disclosures

Similar Posters

First Author: Igor Stukalin

Poster

2017 Genitourinary Cancers Symposium

Real world experience of immuno-oncology agents in metastatic renal cell carcinoma: Results from the IMDC.

Real world experience of immuno-oncology agents in metastatic renal cell carcinoma: Results from the IMDC.

First Author: Steven Yip

First Author: Connor Wells

First Author: Philipp Ivanyi